Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines

Metabolism: Clinical and Experimental

Volumn 63, Issue 2, 2014, Pages 188-193

  Moon, Hyun Seuk ^a   Mantzoros, Christos S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell proliferation; Irisin; Malignant potential; Obesity related cancer

Indexed keywords

HORMONE; IRISIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL ADHESION; CELL PROLIFERATION; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; HORMONE ACTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM; THYROID CANCER;

CELL PROLIFERATION; FIBRONECTIN TYPE III DOMAIN CONTAINING 5; FNDC5; IRISIN; LETO; LONG EVANS TOKUSHIMA OTSUKA RATS; MALIGNANT POTENTIAL; OBESITY-RELATED CANCER; OLETF; OTSUKA LONG-EVANS TOKUSHIMA FATTY RATS; PGC1Α; PROLIFERATOR-ACTIVATED RECEPTOR GAMMA CO-ACTIVATOR 1-Α.;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; ENDOMETRIAL NEOPLASMS; ESOPHAGEAL NEOPLASMS; FEMALE; FIBRONECTINS; HUMANS; MICE; NEOPLASTIC STEM CELLS; THYROID NEOPLASMS;

EID: 84892651185     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.10.005     Document Type: Article

References (24)

1. H.S. Moon, C.S. Chung, H.G. Lee, T.G. Kim, Y.J. Choi, and C.S. Cho Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3 T3-L1 cells Obesity (Silver Spring) 15 2007 2571-2282
2. B. Thakkar, K.N. Aronis, M.T. Vamvini, K. Shields, and C.S. Mantzoros Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies Metabolism 62 2013 922 934
3. D.M. Baur, J. Klotsche, O.P. Hamnvik, C. Sievers, L. Pieper, and H.U. Wittchen et al. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort Metabolism 60 2011 1363 1371
4. W. Tao, and J. Lagergren Clinical management of obese patients with cancer Nat Rev Clin Oncol 10 2013 519 533
5. R.D. Ferguson, E.J. Gallagher, E.J. Scheinman, R. Damouni, and D. LeRoith The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer Vitam Horm 93 2013 51 98
6. S. Birks, A. Peeters, K. Backholer, P. O'Brien, and W. Brown A systematic review of the impact of weight loss on cancer incidence and mortality Obes Rev 13 2012 868 891
7. P. Matafome, D. Santos-Silva, C.M. Sena, and R. Seiça Common mechanisms of dysfunctional adipose tissue and obesity-related cancers Diabetes Metab Res Rev 29 2013 285 295
8. S. Becker, L. Dossus, and R. Kaaks Obesity related hyperinsulinaemia and hyperglycaemia and cancer development Arch Physiol Biochem 115 2009 86 96
9. D. Sharma, N.K. Saxena, P.M. Vertino, and F.A. Anania Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways Endocr Relat Cancer 13 2006 629 640 (Pubitemid 43886682)
10. Z. Li, J. Shen, W.K. Wu, X. Yu, J. Liang, and G. Qiu et al. Leptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK pathways PLoS One 7 2012 e53176
11. H.S. Moon, X. Liu, J.M. Nagel, J.P. Chamberland, K.N. Diakopoulos, and M.T. Brinkoetter et al. Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice Gut 62 2013 561 570
12. M. Dalamaga, K.N. Diakopoulos, and C.S. Mantzoros The role of adiponectin in cancer: a review of current evidence Endocr Rev 33 2012 547 594
13. H.S. Moon, J.P. Chamberland, K. Aronis, S. Tseleni-Balafouta, and C.S. Mantzoros Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans Mol Cancer Ther 10 2011 2234 2243
14. P. Boström, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, and J.C. Lo et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature 481 2012 463 468
15. J.A. Timmons, K. Baar, P.K. Davidsen, and P.J. Atherton Is irisin a human exercise gene? Nature 488 2012 E9 E10 [discussion E10-1]
16. J.Y. Huh, G. Panagiotou, V. Mougios, M. Brinkoetter, M.T. Vamvini, and B.E. Schneider et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise Metabolism 61 2012 1725 1738
17. H.S. Moon, F. Dincer, and C.S. Mantzoros Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines Metabolism 62 2013 1131 1136
18. S.A. Polyzos, J. Kountouras, K. Shields, and C.S. Mantzoros Irisin: a renaissance in metabolism? Metabolism 62 2013 1037 1044
19. F. Villarroya Irisin, turning up the heat Cell Metab 15 2012 277 278
20. M.D. Roberts, D.S. Bayless, J.M. Company, N.T. Jenkins, J. Padilla, and T.E. Childs et al. Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats Metabolism 62 2013 1052 1056
21. A.G. Swick, S. Orena, and A. O'Connor Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass Metabolism 62 2013 1070 1073
22. D.P. Kelly Medicine, irisin, light my fire Science 336 2012 42 43
23. J. Wu, P. Boström, L.M. Sparks, L. Ye, J.H. Choi, and A.H. Giang et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human Cell 150 2012 366 376
24. S.H. Lecker, A. Zavin, P. Cao, R. Arena, K. Allsup, and K.M. Daniels et al. Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure Circ Heart Fail 5 2012 812 818 Diseases